Delivery Order SPE2DE24DA011-SPE2D626F35P8
- Not listed
- The Department of Defense's Medical Supply Chain has awarded a $24,874.12 delivery order to Arthrex Inc. for the Knotless 1.8 Fibertak Implant System, a specialized orthopedic surgical implant product. The award, issued on October 22, 2025, with an ultimate completion date of October 27, 2025, utilizes fixed-price pricing with economic price adjustment terms and does not include a set-aside designation. Arthrex, headquartered in Naples, Florida, will perform the work at its Naples facility and...
- The Defense Logistics Agency's Medical Supply Chain awarded a $29,104.04 fixed-price delivery order with economic price adjustment to Arthrex Inc. for the Knotless 1.8 Fibertak Implant System on November 17, 2025, with ultimate completion by November 20, 2025. This delivery order is issued under Arthrex's existing single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Medical Supply Chain, valued at approximately $471 million and effective through September 1, 2029. The award carries...
- The Department of Defense Medical Supply Chain awarded Arthrex Inc. a $2,805.74 delivery order for Knotless 1.8 Fibertak Implant System medical devices on December 18, 2025, with completion scheduled for December 23, 2025. The award utilized fixed-price pricing with economic price adjustment and carried no set-aside designation, reflecting the contractor's competitive standing in federal procurement. Arthrex, headquartered in Naples, Florida, will perform the work at its Naples facility and will...
- The Defense Logistics Agency's Medical Supply Chain awarded Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, a $3,993.54 fixed-price delivery order with economic price adjustment for a Knotless 1.8 Fibertak Implant System on August 29, 2025. The delivery order, which does not utilize a set-aside designation, is scheduled for completion by September 4, 2025, and will be delivered to Naples, Florida. Arthrex is a global leader in minimally invasive orthopedic...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,271.67 to Arthrex Inc. for the Knotless 1.8 Fibertak Implant System, with completion targeted for December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed at Arthrex's Naples, Florida location. The award represents a task order issued under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Medical Supply...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,163.46 to Arthrex Inc. for a Knotless 1.8 Fibertak Implant System. This fixed-price delivery order, issued on December 11, 2025, with an ultimate completion date of December 18, 2025, represents a task order placed against Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Medical Supply Chain. The award carries no set-aside designation, reflecting Arthrex's competitive position...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $5,112.75 to Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, for DX Knotless Fibertak Implant Kits. This fixed-price delivery order with economic price adjustment was awarded on June 20, 2025, with an ultimate completion date of June 25, 2025, and represents performance at Arthrex's Naples facility. The award was made competitively without set-aside provisions, reflecting Arthrex's...
- The U.S. Department of Defense's Medical Supply Chain awarded a $2,887.50 delivery order to Arthrex Inc. on August 28, 2025, for double loaded knotless Fibertak knee products. This contract, classified as a fixed price delivery order with economic price adjustment provisions, is scheduled for completion by September 3, 2025, and will be performed in Naples, Florida. The award carries no set-aside designation, reflecting Arthrex's competitive standing in the federal orthopedic medical device...
- The Department of Defense's Medical Supply Chain has awarded Arthrex Inc. a delivery order valued at $1,925.22 for a DX Knotless Fibertak Implant Kit, with an ultimate completion date of November 24, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, reflecting Arthrex's competitive position as a prime contractor. The award is performed in Naples, Florida, where Arthrex maintains its headquarters as a leading global manufacturer of...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order on July 14, 2025, for the Knotless 1.8 Fibertak Implant System with a ceiling value of $3,630. This fixed-price delivery order with economic price adjustment is scheduled for completion by July 17, 2025, and will be performed in Naples, Florida. The award was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency...
- SPE2DE24DA011Indefinite Delivery Contract
- SPE2DE24DA011-SPE2D626F35P8Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,257.41 to Arthrex Inc. for the Knotless 1.8 Fibertak Implant System, with a completion date of December 22, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation, reflecting Arthrex's competitive standing in federal procurement. The order will be fulfilled at Arthrex's headquarters location in Naples, Florida, supporting the orthopedic surgical needs of Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order is issued under Arthrex's existing single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Medical Supply Chain, a comprehensive vehicle valued at $471 billion and effective through September 1, 2029. The master contract authorizes procurement of orthopedic products and surgical technologies across the federal healthcare enterprise, enabling rapid access to Arthrex's portfolio of implants, arthroscopic instruments, and surgical systems without competitive re-evaluation for individual task orders. As a prime contractor with no subcontractors, Arthrex maintains direct relationships with federal agencies and fulfills government requirements independently across multiple orthopedic specialties serving veteran and active-duty patient populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 12/16/25 |